<DOC>
	<DOCNO>NCT02940977</DOCNO>
	<brief_summary>1 . To elucidate role CTC detection evaluation risk level PCa patient , establish mathematic model predict pathological status . 2 . To explore possible subtle change CTC condition radical prostatectomy .</brief_summary>
	<brief_title>Establishment Clinical Assessment Prostate Cancer ( PCa ) Risk Model Based Updated Circulating Tumor Cell ( CTC ) Detection Technique</brief_title>
	<detailed_description>1 . Detect evaluate CTC status ( total 5 time : 1 day sugery , 3/6/9/12 surgery ) PCa patient enrol . Analyze CTC result PSA level , needle biopsy radiological imaging information . 2 . Analyze difference CTC amount/Epithelial-Mesenchymal ratio patient different D'Amico risk level ( low/intermediate/high ) . 3 . Establish mathematic model base CTC result pathological condition observe operation ( OC , organ confine ; EPE , extraprostatic extension ; SVI , seminal vesicle invasion ; LNI , lymph node invasion ) , compare model late version Partin table . 4 . Detect compare CTC PSA level every 3 month ( 3/6/9/12 ) surgery . Evaluate radiological condition 12 month blood draw .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Adenoma</mesh_term>
	<mesh_term>Neoplastic Cells , Circulating</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<criteria>1 . Diagnosed PCa biopsy , first time . 2 . Clinical assess suitable radical prostatectomy 3 . Age ≥ 18 year , able provide write informed consent 4 . No prior systematic regional treatment PCa . 5 . No neuroendocrine differentiation small cell PCa pattern . 6 . ECOG status 01 7 . Expected life span ≥ 12 month . 8 . Multiorgan function ( heart , lung , liver , kidney ) able tolerate radical prostatectomy , meet standard study . 1 . Severe concomitant disease infection . 2 . ALT AST &gt; 2.5 ULN , total bilirubin &gt; 1.5 ULN ; Creatinine &gt; 177umol/L ( 2.5mg/dL ) ；Plt &lt; 100,000/uL , Neutrophil &lt; 1,500/uL . 3 . Known suspected brain metastasis leptomeningeal carcinomatosis . 4 . Another malignancy last 5 year , exclude completely cure melanoma . 5 . Severe cardiovascular disease , include : Myocardial infarct within 6 month ; Uncontrolled angina pectoris within 3 month ; Congestive heart failure ; Ventricular arrhythmia history clinical significance ; Morbiz type Ⅱ complete heart block 6 . Major surgery ( general anesthesia ) within 4 week .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Circulating tumor cell</keyword>
	<keyword>Epithelial mesenchymal transition</keyword>
	<keyword>Prostate specific antigen ( PSA )</keyword>
	<keyword>Partin table</keyword>
</DOC>